Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children

BACKGROUND: Mycoplasma pneumoniae (MPP) infections occur regularly every 1 to 3 years. A wave of infections was anticipated around late 2022 to early 2023. However, our data revealed a delayed onset, with a notable increase in cases in 2023/24. This study describes pediatric MPP detections during this resurgence and explores clinical differences between MPP mono-detection and MPP with rhinovirus/enterovirus (RV/EV) co-detection. METHODS: We retrospectively analyzed PCR-confirmed MPP detections in children aged 0-17 years presenting to a tertiary pediatric hospital between 2017 and 2024. Cases from 2017 to 2022 were used as descriptive historical background data (G1, n = 10), while the main analysis focused on the 2023/24 cohort (G2, n = 87). Within this cohort, children with MPP mono-detection were compared with those with MPP plus RV/EV co-detection. Group comparisons were performed using chi-square or Fisher's exact test and t-test or Mann-Whitney U test, as appropriate. RESULTS: Ten sporadic MPP detections occurred between 2017 and 2022, compared with 87 detections in 2023/24, indicating a marked increase in hospital presentations. Because of the small historical group, comparisons with 2023/24 were interpreted descriptively. In the 2023/24 cohort, RV/EV was the most frequent viral co-detection. Compared with children with MPP mono-detection, children with MPP plus RV/EV co-detection were more often male, were less frequently febrile, and showed lower inflammatory parameters, including lower rates of elevated CRP and higher rates of leukopenia and neutropenia. CONCLUSION: In 2023/24, Mycoplasma pneumoniae infections surged dramatically, accompanied by an unprecedented rise in Rhino/Enterovirus coinfections especially in young, male patients. While these findings highlight a potentially important phenotypic pattern, further prospective studies are needed to clarify causality, temporal sequence, and distinct underlying mechanisms.

Authors

Institutions

Publication Details

Journal
Infection
Published
2026-05-27
DOI
https://doi.org/10.1007/s15010-026-02833-8
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children

Melanie Meyer-Bühn, Nicole Maison, B Schaub, Jimmy Omony et al.
Infection
Pneumonia and Respiratory Infections
article

Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children

Melanie Meyer-Bühn, Nicole Maison, B Schaub, Jimmy Omony, C Nagl, L Kolberg, E Brandlmeier, U von Both, Constanze Jakwerth
article en

Abstract

BACKGROUND: Mycoplasma pneumoniae (MPP) infections occur regularly every 1 to 3 years. A wave of infections was anticipated around late 2022 to early 2023. However, our data revealed a delayed onset, with a notable increase in cases in 2023/24. This study describes pediatric MPP detections during this resurgence and explores clinical differences between MPP mono-detection and MPP with rhinovirus/enterovirus (RV/EV) co-detection. METHODS: We retrospectively analyzed PCR-confirmed MPP detections in children aged 0-17 years presenting to a tertiary pediatric hospital between 2017 and 2024. Cases from 2017 to 2022 were used as descriptive historical background data (G1, n = 10), while the main analysis focused on the 2023/24 cohort (G2, n = 87). Within this cohort, children with MPP mono-detection were compared with those with MPP plus RV/EV co-detection. Group comparisons were performed using chi-square or Fisher's exact test and t-test or Mann-Whitney U test, as appropriate. RESULTS: Ten sporadic MPP detections occurred between 2017 and 2022, compared with 87 detections in 2023/24, indicating a marked increase in hospital presentations. Because of the small historical group, comparisons with 2023/24 were interpreted descriptively. In the 2023/24 cohort, RV/EV was the most frequent viral co-detection. Compared with children with MPP mono-detection, children with MPP plus RV/EV co-detection were more often male, were less frequently febrile, and showed lower inflammatory parameters, including lower rates of elevated CRP and higher rates of leukopenia and neutropenia. CONCLUSION: In 2023/24, Mycoplasma pneumoniae infections surged dramatically, accompanied by an unprecedented rise in Rhino/Enterovirus coinfections especially in young, male patients. While these findings highlight a potentially important phenotypic pattern, further prospective studies are needed to clarify causality, temporal sequence, and distinct underlying mechanisms.

Infection
Center for Environmental Health (US), Helmholtz Zentrum München (DE), LMU Klinikum (DE), German Center for Pediatric and Adolescent Rheumatology (DE), German Center for Infection Research (DE), German Center for Lung Research (DE), Ludwig-Maximilians-Universität München (DE)
Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsches Zentrum für Lungenforschung
Good health and well-being
Openalex Percentile: Top 6%
Pneumonia and Respiratory Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.